Singapore, April 13 -- The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) announces that Drug Controller General of India (DCGI) has approved the use of the Russian Sputnik V vaccine against coronavirus in the country. India has become the 60th country to approve Sputnik V.

Sputnik V is one of only three coronavirus vaccines registered by India's regulatory authorities.

India is the most populated country to register the Russian vaccine. Total population of 60 countries where Sputnik V is approved for use is 3 billion people or about 40% of the global population.

The vaccine has been registered in India under the emergency use authorization procedure based on results of clinical trials in Russia as well as positi...